Stem Cell Therapy Cost in Singapore

A. The patient is expected to remain in the guest house for an additional 15 days following stem cell therapy in Singapore. It is advised that you stay for this long to finish all the follow-ups and control tests required to make sure the surgery went well.

A. The patient must pay extra for daily meals and other package-related services in addition to the cost of stem cell therapy. These fees could start at USD 150 per person.

A. In Singapore, stem cell therapy is available in practically every major city, including the following:

• Singapore

A. The patient is expected to remain in the hospital for a few weeks following stem cell therapy to recuperate and be monitored. To make sure the patient is healing properly and is clinically stable, this stage is important. Before the patient is considered fit for discharge, many tests are conducted during this time.

A. Hospitals in Singapore offering stem cell therapy are highly rated. This rating is automatically calculated based on several parameters such as the facilities of the hospital, quality of services, nursing support, and other services.

A. There are more than one hospitals that offer Stem Cell Therapy in Singapore. The above-mentioned clinics have the required facilities and a dedicated unit where patients can be treated. Also, these hospitals follow the necessary guidelines as required by the medical associations for the treatment of Stem Cell Therapy patients.

A. Some of the top doctors for Stem Cell Therapy in Singapore are:

1. Dr. Tan Yu Meng
2. Dr. Lim Zi Yi
3. Dr. Angeline Goh Ting Hui
4. Dr. Ho Chee Khun
5. Dr. Chia Chung King
6. Dr. Ng Tsun Gun

A. Depending on the illness being treated, stem cell therapy has varying overall success rates. The success rate of stem cell therapy three years after diagnosis, 72% of patients with non-Hodgkin lymphoma, compared to 92% of patients with Hodgkin lymphoma got chemotherapy and a transplant.

A. When it comes to stem cell therapy, the recovery period generally depends on the kind of procedure, as it can take anywhere from a few days to even several months.

One can return to normal activities within days or weeks. The actual procedure is mostly completed within a few hours, and patients are usually able to walk out by themselves. In certain cases, soreness and stiffness may be felt in the treated area, possibly with some mild pain at the site from where the stem cells were harvested. Pain relief may start as early as two weeks, to 12 weeks, and most continue to improve over the next 6 months or so.

The recovery period differs based on whether the stem cells were from the patient or another person:

• Autologous transplant: Recovery takes about three to six months.
• Allogenic transplant: Recovery will potentially last between twelve to eighteen months. Patients need to stay in the hospital for four weeks or longer.

A. Risks associated with stem cell treatment include:

• Short-term side effects: Skin reactions, mouth sores, hair loss, exhaustion, nausea, and vomiting
• Infections: One of the most frequent early side effects is infection. For the first few weeks following the transplant, you might have to remain in a germ-free hospital room.
• Bleeding: Your blood may clot more slowly if your platelet levels are low, which might cause bleeding.
• Anemia: Low hemoglobin concentration in red blood cells or a low red blood cell count are both considered anemia.
• Graft-versus-host disease (GVHD): Following an allogeneic stem cell transplant, this condition may occur.
• Veno-occlusive disease (VOD) is caused by blockages in the tiny blood arteries that supply the liver.
• Digestive issues: The chemotherapy medications administered before the transplant may cause sensitivity in the tissues of your mouth, stomach, and intestines.
• Skin and hair issues: GVHD and the pre-transplant treatment may result in skin issues.
• Secondary malignancies: The development of secondary cancers is a possibility.
• Other dangers consist of:
  • Cataracts
  • Infertility
  • Damage to the liver
  • Dry and damaged mouth, esophagus, and other organs

A. Stem cell therapy can treat several diseases, such as:

• Blood conditions: The primary use of stem cell transplants is to treat cancers of the blood like leukemia, lymphoma, and multiple myeloma, and blood disorders like sickle cell disease and aplastic anemia.
• Diabetes: Stem cells help to heal wounds in diabetics by bringing about growth factors that induce the regeneration of tissue.
• Cardiovascular diseases: Stem cell therapy can help prevent cardiovascular diseases that deprive the heart of oxygen, resulting in scarring.
• Renal disorders: Studies have demonstrated stem cell therapy to be beneficial in experimental models of acute kidney damage.
• Repair of the cornea: Stem cell therapy can heal injuries such as chemical burns to the cornea.
• Skin transplants: Stem cell research may be applied in growing skin transplants for patients suffering from serious burns.
• Macular degeneration: Stem cell-based clinical trials are also being conducted for the treatment of macular degeneration, which constitutes one of the most common forms of age-related blindness.
• Stem cells can also be employed to treat such other diseases as:
  • Parkinson's disease
  • Alzheimer's disease
  • Spinal cord injury
  • Arthritis
  • Immunodeficiencies

A. Some of the common pre-treatment tests and procedures for stem cell therapy are as follows:

• Psychological evaluation: A psychological evaluation is required to determine patient eligibility for stem cell therapy.
• Blood tests: Blood tests are done to determine patient eligibility for stem cell therapy.
• Bone marrow tests: Bone marrow tests are done to determine patient eligibility for stem cell therapy.
• Chest X-rays and CT scans: Chest X-rays and CT scans are done to determine patient eligibility for stem cell therapy.
• Heart, lung, and all organs function check: Evaluation of the function of the heart, lung, and other organs is done to see if the patient qualifies for stem cell therapy.
• HLA tests: If a donor is being used, their human leukocyte antigens (HLAs) are tested to determine if they are a match for the recipient. The donor and recipient with more similar HLAs have a better chance of acceptance of the donor's stem cells.
• Donor tests: The donor's medical history is evaluated for infectious diseases that they may transmit to the recipient. Their cells are checked for exposure to any infectious agents.
• Preparative regimen: In the days leading up to the transplant, the patient will undergo chemotherapy and radiation therapy to prepare their bodies to receive the new stem cells. This is called conditioning treatment.

A. Several factors influence the suitability of an individual for stem cell therapy, among which include:

• General health: Patients must be strong enough to tolerate the side effects of both chemotherapy and the stem cell transplant itself.
• Medical condition: Not all types of cancers and blood disorders are responsive to stem cell transplants.
• Previous treatment: Certain treatments may influence and cause the efficacy of a transplant.
• Source of stem cells: In this respect, the stem cells may have either been obtained from the patient or a donor.
• Radiation treatment: The patient's tolerance for radiation treatment and the resultant side effects of that treatment.
• Severity of disease: The extent of the patient's disease condition is a factor considered for eligibility.
• Response: The expected response of the individual disease of the patient to transplantation.

Stem cell therapy may be beneficial for individuals with leukemia, Hodgkin disease, non-Hodgkin lymphoma, aplastic anemia, immunodeficiencies, and some inherited metabolic disorders.

A. Yes, the clinical trials for stem cell therapy are being conducted in Singapore also. Singapore is a leader in stem cell research and regenerative medicine. The country is characterized by the existence of vigorous regulatory frameworks and a commitment to the performance of clinical trials. The goals of Singapore include:

• Developing and manufacturing cell-based therapies for a wide range of diseases.
• Being a medical hub for foreign patients seeking stem cell-based treatment
• Addressing the regulatory, safety, efficacy, and commercial challenges presented to stem cell therapy.